The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable buzz within the industry. A shift away from Schedule I status, often considered as outdated and hindering https://bookmarkloves.com/story23102434/cannabinoid-rescheduling-a-growth-catalyst